# Abundia Global Impact Group, Inc.: financial statements, quarterly AGIG · NYSE · CIK 1156041 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/agig.md) · [Financials](/companies/agig/financials.md) · [Filings](/companies/agig/filings.md) · [Insiders](/companies/agig/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/agig/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.1](/filings/0001493152-24-045988.md) | [0.2 d](/filings/0001641172-25-007857.md) | [0.1](/filings/0001641172-25-009427.md) | [0.1](/filings/0001641172-25-024233.md) | [0.1](/filings/0001493152-24-045988.md) | [0.2 d](/filings/0001641172-25-007857.md) | [0.1](/filings/0001641172-25-009427.md) | [0.5](/filings/0001493152-26-036491.md) | [0.2](/filings/0001493152-26-005642.md) | [0.2 d](/filings/0001493152-26-022630.md) | [0.1](/filings/0001493152-26-021867.md) | [2.0](/filings/0001493152-26-036491.md) | | Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.8](/filings/0001493152-26-036491.md) | not reported | not reported | not reported | [1.4](/filings/0001493152-26-036491.md) | | Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [(0.3)](/filings/0001493152-26-036491.md) | not reported | not reported | not reported | [0.6](/filings/0001493152-26-036491.md) | | Research and development | $m | not reported | not reported | not reported | not reported | [0.1](/filings/0001493152-26-005642.md) | [0.1 d](/filings/0001493152-26-022630.md) | [0.6](/filings/0001493152-26-021867.md) | [0.1](/filings/0001493152-26-036491.md) | [0.0 d](/filings/0001493152-26-005642.md) | [0.0 d](/filings/0001493152-26-022630.md) | [0.2](/filings/0001493152-26-021867.md) | [0.2](/filings/0001493152-26-036491.md) | | Operating income | $m | [(0.4)](/filings/0001493152-24-045988.md) | [(3.3) d](/filings/0001641172-25-007857.md) | [(0.4)](/filings/0001641172-25-009427.md) | [(0.4)](/filings/0001641172-25-024233.md) | [(0.5)](/filings/0001493152-26-005642.md) | [(4.7) d](/filings/0001493152-26-022630.md) | [(1.6)](/filings/0001493152-26-021867.md) | [(1.9)](/filings/0001493152-26-036491.md) | [(20.1)](/filings/0001493152-26-005642.md) | [(5.9) d](/filings/0001493152-26-022630.md) | [(5.1)](/filings/0001493152-26-021867.md) | [(3.4)](/filings/0001493152-26-036491.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | [0.1](/filings/0001493152-26-005642.md) | [0.1 d](/filings/0001493152-26-022630.md) | [0.1](/filings/0001493152-26-021867.md) | [0.1](/filings/0001493152-26-036491.md) | [0.1](/filings/0001493152-26-005642.md) | [0.1 d](/filings/0001493152-26-022630.md) | [0.1](/filings/0001493152-26-021867.md) | [0.1](/filings/0001493152-26-036491.md) | | Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net income | $m | [0.2](/filings/0001493152-24-045988.md) | [(3.2) d](/filings/0001641172-25-007857.md) | [(2.1)](/filings/0001493152-25-024335.md) | [0.4](/filings/0001493152-25-024335.md) | [(0.3)](/filings/0001493152-26-005642.md) | [(1.7) d](/filings/0001493152-26-022630.md) | [(1.0)](/filings/0001493152-26-005642.md) | [(1.9)](/filings/0001493152-26-036491.md) | [(20.4)](/filings/0001493152-26-005642.md) | [(6.9) d](/filings/0001493152-26-022630.md) | [(5.2)](/filings/0001493152-26-021867.md) | [(3.5)](/filings/0001493152-26-036491.md) | | Diluted EPS | $ per share | [0.02](/filings/0001493152-24-045988.md) | not reported | [0.00](/filings/0001641172-25-009427.md) | [(0.08)](/filings/0001641172-25-024233.md) | [(0.01)](/filings/0001493152-26-005642.md) | not reported | [(0.03)](/filings/0001493152-26-021867.md) | [(0.06)](/filings/0001493152-26-036491.md) | [(0.60)](/filings/0001493152-26-005642.md) | not reported | [(0.13)](/filings/0001493152-26-021867.md) | [(0.08)](/filings/0001493152-26-036491.md) | | Basic EPS | $ per share | [0.02](/filings/0001493152-24-045988.md) | not reported | [0.00](/filings/0001641172-25-009427.md) | [(0.08)](/filings/0001641172-25-024233.md) | [(0.01)](/filings/0001493152-26-005642.md) | not reported | [(0.03)](/filings/0001493152-26-021867.md) | [(0.06)](/filings/0001493152-26-036491.md) | [(0.60)](/filings/0001493152-26-005642.md) | not reported | [(0.13)](/filings/0001493152-26-021867.md) | [(0.08)](/filings/0001493152-26-036491.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: not reported - Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [4.5](/filings/0001493152-23-041141.md) | [4.1](/filings/0001641172-25-007857.md) | [3.8](/filings/0001493152-24-020015.md) | [3.4](/filings/0001493152-24-032176.md) | [2.8](/filings/0001493152-24-045988.md) | [0.5](/filings/0001493152-26-022630.md) | [5.3](/filings/0001641172-25-009427.md) | [7.0](/filings/0001641172-25-024233.md) | [1.5](/filings/0001493152-26-005642.md) | [4.8](/filings/0001493152-26-036491.md) | [16.2](/filings/0001493152-26-021867.md) | [11.2](/filings/0001493152-26-036491.md) | | Current assets | $m | [4.9](/filings/0001493152-23-041141.md) | [4.2](/filings/0001641172-25-007857.md) | [3.9](/filings/0001493152-24-020015.md) | [3.5](/filings/0001493152-24-032176.md) | [3.1](/filings/0001493152-24-045988.md) | [0.9](/filings/0001493152-26-022630.md) | [5.9](/filings/0001641172-25-009427.md) | [7.5](/filings/0001641172-25-024233.md) | [2.4](/filings/0001493152-26-005642.md) | [6.3](/filings/0001493152-26-036491.md) | [16.7](/filings/0001493152-26-021867.md) | [11.8](/filings/0001493152-26-036491.md) | | Total assets | $m | [14.0](/filings/0001493152-23-041141.md) | [10.4](/filings/0001641172-25-007857.md) | [10.5](/filings/0001493152-24-020015.md) | [10.4](/filings/0001493152-24-032176.md) | [10.2](/filings/0001493152-24-045988.md) | [4.1](/filings/0001493152-26-022630.md) | [7.2](/filings/0001641172-25-009427.md) | [8.7](/filings/0001641172-25-024233.md) | [28.8](/filings/0001493152-26-005642.md) | [34.3](/filings/0001493152-26-036491.md) | [45.6](/filings/0001493152-26-021867.md) | [48.5](/filings/0001493152-26-036491.md) | | Current liabilities | $m | [0.6](/filings/0001493152-23-041141.md) | [0.2](/filings/0001641172-25-007857.md) | [0.3](/filings/0001493152-24-020015.md) | [0.3](/filings/0001493152-24-032176.md) | [0.3](/filings/0001493152-24-045988.md) | [6.2](/filings/0001493152-26-022630.md) | [0.1](/filings/0001641172-25-009427.md) | [0.2](/filings/0001641172-25-024233.md) | [6.3](/filings/0001493152-26-005642.md) | [7.3](/filings/0001493152-26-036491.md) | [10.1](/filings/0001493152-26-021867.md) | [19.9](/filings/0001493152-26-036491.md) | | Total liabilities | $m | [0.7](/filings/0001493152-23-041141.md) | [0.4](/filings/0001641172-25-007857.md) | [0.5](/filings/0001493152-24-020015.md) | [0.4](/filings/0001493152-24-032176.md) | [0.4](/filings/0001493152-24-045988.md) | [6.2](/filings/0001493152-26-022630.md) | [0.2](/filings/0001641172-25-009427.md) | [0.3](/filings/0001641172-25-024233.md) | [12.5](/filings/0001493152-26-005642.md) | [13.8](/filings/0001493152-26-036491.md) | [10.3](/filings/0001493152-26-021867.md) | [20.1](/filings/0001493152-26-036491.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [10.2](/filings/0001493152-26-022630.md) | [6.8](/filings/0001493152-26-021867.md) | [11.3](/filings/0001493152-26-036491.md) | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [5.9](/filings/0001493152-26-005642.md) | not reported | not reported | [6.2](/filings/0001493152-26-005642.md) | not reported | not reported | not reported | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [5.9](/filings/0001493152-26-005642.md) | not reported | not reported | [5.0](/filings/0001493152-26-005642.md) | not reported | not reported | not reported | | Shareholders' equity | $m | [13.2](/filings/0001493152-24-045988.md) | [10.0](/filings/0001641172-25-024233.md) | [(0.5)](/filings/0001493152-26-005642.md) | [10.0](/filings/0001641172-25-024233.md) | [9.8](/filings/0001493152-24-045988.md) | [(2.1)](/filings/0001493152-26-005642.md) | [(2.6)](/filings/0001493152-26-005642.md) | [8.4](/filings/0001641172-25-024233.md) | [16.3](/filings/0001493152-26-005642.md) | [20.6](/filings/0001493152-26-036491.md) | [36.6](/filings/0001493152-26-036491.md) | [28.4](/filings/0001493152-26-036491.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Current portion of debt: us-gaap:DebtCurrent, us-gaap:LongTermDebtCurrent - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [6.0 d](/filings/0001493152-24-045988.md) | [475 d](/filings/0001641172-25-007857.md) | [123](/filings/0001641172-25-009427.md) | [(35.0) d](/filings/0001641172-25-024233.md) | [(1,460) d](/filings/0001493152-26-005642.md) | [(552) d](/filings/0001493152-26-022630.md) | [(1,121)](/filings/0001493152-26-021867.md) | [(1,120) d](/filings/0001493152-26-036491.md) | [(2,365) d](/filings/0001493152-26-005642.md) | [(3,446) d](/filings/0001493152-26-022630.md) | [(3,760)](/filings/0001493152-26-021867.md) | [1,460 d](/filings/0001493152-26-036491.md) | | Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1,671](/filings/0001493152-26-021867.md) | [4,138 d](/filings/0001493152-26-036491.md) | | Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: not reported - Share repurchases: not reported ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [10.4](/filings/0001493152-23-041141.md) | [10.8](/filings/0001493152-24-020015.md) | [10.9](/filings/0001493152-24-032176.md) | [10.9](/filings/0001493152-24-045988.md) | [10.9](/filings/0001641172-25-009427.md) | [1.1](/filings/0001641172-25-024233.md) | [31.8](/filings/0001493152-26-005642.md) | [31.8](/filings/0001493152-26-021867.md) | [31.8](/filings/0001493152-26-036491.md) | [34.0](/filings/0001493152-26-005642.md) | [40.0](/filings/0001493152-26-021867.md) | [44.0](/filings/0001493152-26-036491.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 44,150,321 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001493152-26-036491.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.